Table 3. Absolute incidence rate difference between IBS cases and controls for each disease stratified by current age and time since IBS diagnosis.
Current age | Time since IBS diagnosis | Coeliac disease | IBD | CRC | |||
Absolute rate difference (per 10000 person years) | 95% CI | Absolute rate difference (per 10000 person years) | 95% CI | Absolute rate difference (per 10000 person years) | 95% CI | ||
18–29 | 0–6 months | 15.10 | 4.83–16.45 | 66.25 | 51.66–80.84 | 3.14 | 0.06–6.23 |
6–12 months | 7.20 | 0.43–9.22 | 38.26 | 26.20–50.33 | 0.90 | −0.86–2.66 | |
1–5 years | 4.00 | 1.46–4.71 | 18.51 | 14.35–22.67 | −0.57 | −1.03– −0.12 | |
5–10 years | 3.60 | −0.87–6.51 | 12.62 | 5.26–19.99 | - | - | |
10 years to end of follow-up | - | - | 9.62 | −4.99–6.91 | - | - | |
30–49 | 0–6 months | 17.40 | 9.34–19.38 | 55.21 | 45.45–64.98 | 17.44 | 10.07–22.80 |
6–12 months | 4.70 | 1.66–7.98 | 32.39 | 24.61–40.16 | 3.93 | 1.18–6.67 | |
1–5 years | 2.60 | 1.34–3.35 | 11.73 | 9.72–13.74 | 0.94 | 0.18–1.69 | |
5–10 years | 2.40 | 0.13–2.60 | 4.87 | 2.83–6.91 | 0.05 | −0.79–0.89 | |
10 years to end of follow-up | 1.10 | −0.51–3.05 | 5.88 | 2.49–9.27 | −0.26 | −1.96–1.44 | |
50–74 | 0–6 months | 11.7 | 6.4–16.9 | 39.52 | 29.88–49.16 | 83.46 | 69.09–97.84 |
6–12 months | 4.7 | 0.8–8.5 | 16.93 | 10.09–23.78 | 24.65 | 15.56–33.76 | |
1–5 years | 3.1 | 1.8–4.4 | 9.75 | 7.61–11.90 | 2.69 | 0.50–4.89 | |
5–10 years | 2.7 | 1.3–4.0 | 6.49 | 4.40–8.59 | 0.37 | −4.85–2.59 | |
10 years to end of follow-up | 2.8 | 0.8–4.8 | 3.94 | 1.57–6.31 | −1.09 | −4.14–1.95 | |
75 and older | 0–6 months | - | - | - | - | 94.64 | −939.23–496.49 |
6–12 months | - | - | - | - | - | - | |
1–5 years | −0.8 | −3.9–2.3 | 6.14 | −2.85–15.14 | −4.59 | −17.97–0.78 | |
5–10 years | 2.0 | −0.1–4.9 | 3.21 | −1.79–8.21 | 4.58 | −6.34–15.54 | |
10 years to end of follow-up | 2.4 | −1.5–6.3 | 5.06 | 0.05–10.10 | −1.76 | −12.01–8.49 |
Rates in bold are statistically significant with a p-value <0.05 The absolute rate difference indicates how many additional people would be expected to be diagnosed with each condition in a group with IBS, rather than the proportional difference that is presented in the rate ratio measure.